China’s Wu Capital leads $91.5m Series A round in genetic firm Korro Bio

China’s Wu Capital leads $91.5m Series A round in genetic firm Korro Bio

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter